# PRESS RELEASE 2015

- ## [Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX® (budesonide) in Japan](/content/cosmo-ferring-pharmaceuticals-enter-into-licensing-agreement-for-cortimentmmx-budesonide-in-japan/index.html)

Ferring Pharmaceuticals announced today that it has signed a licensing agreement with Ferring Pharmaceuticals…

- ## [Ferring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label](/content/ferring-pharmaceuticals-submits-variation-application-to-introduce-new-tailored-dosing-regimen-in-the-picoprep/index.html)

Ferring Pharmaceuticals announced today that it has submitted a variation application in the Mutual Recognition…

- ## [Ferring receives acceptance of Marketing Authorisation filing from EMA for personalised fertility treatment with REKOVELLE® (follitropin delta)](/content/ferring-receives-acceptance-of-marketing-authorisation/index.html)

Ferring Pharmaceuticals announced today that the filing for the Marketing Authorisation Application for…

- ## [Ferring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)](/content/ferring-pharmaceuticals-acquires-global-rights-to-milprosa-progesterone-vaginal-ring/index.html)

Ferring Pharmaceuticals announced today that it has acquired the global rights to MILPROSATM (progesterone vaginal ring) from Teva Women’s…

- ## [Ferring Pharmaceuticals begins Phase 2b/3 trial of selepressin for treatment of septic shock](/content/ferring-pharmaceuticals-begins-phase-2b-3-trial-of-selepressin-for-treatment-of-septic-shock/index.html)

Ferring Pharmaceuticals announced initiation of patient enrollment in a phase 2b/3 clinical trial of selepressin for the treatment of septic shock…

- ## [Ferring Pharmaceuticals moves forward with early stage development of bacteriophage therapy for inflammatory bowel disease](/content/ferring-pharmaceuticals-moves-forward-with-early-stage-development-of-bacteriophage-therapy-for-inflammatory-bowel-disease/index.html)

Ferring Pharmaceuticals announced today that it will collaborate with Baltimore-based Intralytix, Inc…

- ## [Inflammatory Bowel Disease Treatment Gets Boost From New Educational Resource](/content/inflammatory-bowel-disease-treatment-gets-boost-from-new-educational-resource/index.html)

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD)…

- ## [Ferring and the Institut Pasteur collaborate in novel IBD drug development project](/content/ferring-and-the-institut-pasteur-collaborate-in-novel-ibd-drug-development-project/index.html)

Ferring Pharmaceuticals a research-driven, specialty biopharmaceutical group and the Institut Pasteur, a non-profit international biomedical…

- ## [Ferring announces European approval of new room temperature stable formulation of PABAL® (carbetocin)](/content/ferring-announces-european-approval-of-new-room-temperature-stable-formulation-of-pabal-carbetocin/index.html)

Ferring announced today that its new room-temperature-stable formulation of PABAL® (carbetocin) for intravenous (IV) administration…

- ## [Ferring Pharmaceuticals acquires novel drug delivery technology from CTCBIO Inc.](/content/ferring-pharmaceuticals-acquires-novel-drug-delivery-technology-from-ctcbio-inc/index.html)

Ferring Pharmaceuticals announced today that it has signed an agreement with CTCBIO Inc. of Seoul, South Korea to acquire rights to…